Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F20KW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $45,984
Award facts
- Contract value 100% obligated
- $45,984.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at approximately $46,000 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors, with performance completion targeted for January 8, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.99 million through December 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to military healthcare systems globally.
Repatha (evolocumab) is a PCSK9 inhibitor used for cholesterol management in patients at high risk for cardiovascular events, and its inclusion in the federal medical supply chain reflects ongoing support for preventive healthcare within the military health system. AmerisourceBergen's extensive portfolio of federal pharmaceutical contracts demonstrates its critical role as a pharmaceutical distributor serving Defense Health Agency requirements and other federal healthcare organizations. The delivery order structure and firm fixed-price model ensure transparent cost management while enabling the DLA to procure essential cardiovascular therapeutics through an established, proven supplier relationship.
Quick answers
Who was awarded contract SPE2DR26F20KW?
SPE2DR26F20KW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F20KW worth?
The government has obligated $45,984 on SPE2DR26F20KW.
Is contract SPE2DR26F20KW an order under another contract?
Yes. SPE2DR26F20KW is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F20KW competed?
The extent of competition for SPE2DR26F20KW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award